Procarbazine (NSC-77213) in the treatment of advanced bronchogenic carcinoma

Clinical Trial

M L Samuels et al. Cancer Chemother Rep. 1969 Apr.

. 1969 Apr;53(2):135-45.

No abstract available

Similar articles

[Modalities and results of anticancer polychemotherapy in 73 cases of advanced broncho-pleuro-pulmonary cancer].
Reboul AR, Lewest G. Reboul AR, et al. Poumon Coeur. 1968;24(1):117-23. Poumon Coeur. 1968. PMID: 5661797 French. No abstract available.
[Results of a new trial of prolonged polychemotherapy of inoperable broncho-pulmonary cancers (apropos of 173 cases)].
Decroix G, Sors C, Feldman A, Fournier M. Decroix G, et al. Bull Mem Soc Med Hop Paris. 1968 Jan-Feb;119(2):169-78. Bull Mem Soc Med Hop Paris. 1968. PMID: 5670365 French. No abstract available.
[218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
Israel L, Bernard E. Israel L, et al. Poumon Coeur. 1968;24(1):63-8. Poumon Coeur. 1968. PMID: 5690023 French. No abstract available.
Chemotherapy in management of bronchogenic carcinoma.
Samuels ML, Leary WV, Howe CD. Samuels ML, et al. Tex Med. 1967 Dec;63(12):86-92. Tex Med. 1967. PMID: 4867418 Review. No abstract available.
Metabolism of hydrazine anti-cancer agents.
Tweedie DJ, Erikson JM, Prough RA. Tweedie DJ, et al. Pharmacol Ther. 1987;34(1):111-27. doi: 10.1016/0163-7258(87)90095-7. Pharmacol Ther. 1987. PMID: 3310042 Review. No abstract available.

Combination chemotherapy (high-dose methotrexate with citrovorum factor rescue, mechlorethamine, and procarbazine) in non-small cell lung cancer.
Bhasin RR, Nogeirie CP. Bhasin RR, et al. Cancer Chemother Pharmacol. 1983;11(2):106-7. doi: 10.1007/BF00254256. Cancer Chemother Pharmacol. 1983. PMID: 6605217
Antineoplastic drugs in 1990. A review (Part II).
Black DJ, Livingston RB. Black DJ, et al. Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003. Drugs. 1990. PMID: 2191847 Review. No abstract available.